Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:19595065rdf:typepubmed:Citationlld:pubmed
pubmed-article:19595065lifeskim:mentionsumls-concept:C0007634lld:lifeskim
pubmed-article:19595065lifeskim:mentionsumls-concept:C0684249lld:lifeskim
pubmed-article:19595065lifeskim:mentionsumls-concept:C0007589lld:lifeskim
pubmed-article:19595065lifeskim:mentionsumls-concept:C1257792lld:lifeskim
pubmed-article:19595065lifeskim:mentionsumls-concept:C0013203lld:lifeskim
pubmed-article:19595065lifeskim:mentionsumls-concept:C0205263lld:lifeskim
pubmed-article:19595065lifeskim:mentionsumls-concept:C1511938lld:lifeskim
pubmed-article:19595065lifeskim:mentionsumls-concept:C0599473lld:lifeskim
pubmed-article:19595065pubmed:issue10lld:pubmed
pubmed-article:19595065pubmed:dateCreated2009-7-14lld:pubmed
pubmed-article:19595065pubmed:abstractTextTo study the chiral selectivity in vascular endothelial differentiation in drug resistant lung cancer cells induced by high-dose L- or D-methotrexate (MTX) enantiomer.lld:pubmed
pubmed-article:19595065pubmed:languagechilld:pubmed
pubmed-article:19595065pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:19595065pubmed:citationSubsetIMlld:pubmed
pubmed-article:19595065pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:19595065pubmed:statusMEDLINElld:pubmed
pubmed-article:19595065pubmed:monthMarlld:pubmed
pubmed-article:19595065pubmed:issn0376-2491lld:pubmed
pubmed-article:19595065pubmed:authorpubmed-author:LiMingMlld:pubmed
pubmed-article:19595065pubmed:authorpubmed-author:ShenZuo-JunZJlld:pubmed
pubmed-article:19595065pubmed:authorpubmed-author:LinDongDlld:pubmed
pubmed-article:19595065pubmed:authorpubmed-author:HeXiao-DongXDlld:pubmed
pubmed-article:19595065pubmed:authorpubmed-author:ZhuYuan-YuanY...lld:pubmed
pubmed-article:19595065pubmed:authorpubmed-author:HuShi-LianSLlld:pubmed
pubmed-article:19595065pubmed:authorpubmed-author:TaoShao-NengS...lld:pubmed
pubmed-article:19595065pubmed:issnTypePrintlld:pubmed
pubmed-article:19595065pubmed:day17lld:pubmed
pubmed-article:19595065pubmed:volume89lld:pubmed
pubmed-article:19595065pubmed:ownerNLMlld:pubmed
pubmed-article:19595065pubmed:authorsCompleteYlld:pubmed
pubmed-article:19595065pubmed:pagination690-4lld:pubmed
pubmed-article:19595065pubmed:meshHeadingpubmed-meshheading:19595065...lld:pubmed
pubmed-article:19595065pubmed:meshHeadingpubmed-meshheading:19595065...lld:pubmed
pubmed-article:19595065pubmed:meshHeadingpubmed-meshheading:19595065...lld:pubmed
pubmed-article:19595065pubmed:meshHeadingpubmed-meshheading:19595065...lld:pubmed
pubmed-article:19595065pubmed:meshHeadingpubmed-meshheading:19595065...lld:pubmed
pubmed-article:19595065pubmed:meshHeadingpubmed-meshheading:19595065...lld:pubmed
pubmed-article:19595065pubmed:meshHeadingpubmed-meshheading:19595065...lld:pubmed
pubmed-article:19595065pubmed:meshHeadingpubmed-meshheading:19595065...lld:pubmed
pubmed-article:19595065pubmed:meshHeadingpubmed-meshheading:19595065...lld:pubmed
pubmed-article:19595065pubmed:meshHeadingpubmed-meshheading:19595065...lld:pubmed
pubmed-article:19595065pubmed:meshHeadingpubmed-meshheading:19595065...lld:pubmed
pubmed-article:19595065pubmed:year2009lld:pubmed
pubmed-article:19595065pubmed:articleTitle[Chiral selectivity in differentiation of lung cancer A549 cell to vascular endothelial cells after drug resistance induced by D-or L-methotrexate enantiomers].lld:pubmed
pubmed-article:19595065pubmed:affiliationAnhui Provincial Center for Clinical Laboratories, Anhui Provincial Hospital Affiliated to Anhui Medical University, Hefei 230001, China.lld:pubmed
pubmed-article:19595065pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:19595065pubmed:publicationTypeEnglish Abstractlld:pubmed
pubmed-article:19595065pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed